Smart syringe market was valued at $5,737 million in 2017, and is estimated to garner $13,792 million by 2025, registering a CAGR of 10.3% during the forecast period. Smart syringes are designed with features to offer protection from needle stick injuries, blood-borne diseases such as hepatitis C virus (HCV), hepatitis B virus (HBV), human immunodeficiency virus (HIV), and life-threatening infections. They cater to several applications that include vaccination, drug delivery, and blood specimen collection. Smart syringes are of various types, which include auto-disable (AD) syringes, passive safety syringes, and active safety syringes are used depending on the nature of application. Active safety syringes are the most common type of smart syringes used across all healthcare sectors, whereas, auto disable (AD) syringes are the most popular syringes used for vaccination purpose.
Major Key Players of the Smart Syringe Market are:Welltok, Intel Corporation, Nvidia Corporation, Google, IBM Corporation, Microsoft Corporation, General Vision, Inc., Enlitic, Inc., BioXcel Corporation, Berg Health
Read More @ http://www.sbwire.com/press-releases/smart-syringe-market-to-witness-an-outstanding-growth-during-2018-2025-welltok-intel-nvidia-google-1286092.htm
Major Key Players of the Smart Syringe Market are:Welltok, Intel Corporation, Nvidia Corporation, Google, IBM Corporation, Microsoft Corporation, General Vision, Inc., Enlitic, Inc., BioXcel Corporation, Berg Health
Read More @ http://www.sbwire.com/press-releases/smart-syringe-market-to-witness-an-outstanding-growth-during-2018-2025-welltok-intel-nvidia-google-1286092.htm
No comments:
Post a Comment